Skip to main content
Top

Experimental Hematology & Oncology

2012 - 2025
Volumes
14
Issues
Chevron right icon
Issue 1/2025
Latest issue

About this journal

Experimental Hematology & Oncology publishes preclinical, basic, patient-oriented and translational research in all areas of hematology and oncology. The journal acts as an international platform for sharing laboratory findings and makes a deliberate effort to publish clinical trials with 'negative' results, as well as basic science studies with provocative findings. This peer-reviewed, open access journal offers impressive turnaround times with a time to first decision of less than 30 days.

Metadata
Title
Experimental Hematology & Oncology
Coverage
Volume 1/2012 - Volume 14/2025
Publisher
BioMed Central
Electronic ISSN
2162-3619
Journal ID
40164

ASH 2024 Annual Meeting Coverage

inMIND supports tafasitamab addition in follicular lymphoma

Combining tafasitamab with lenalidomide and rituximab significantly improves progression-free survival for patients with relapsed or refractory follicular lymphoma.

Featuring the official presentation video

Read more
SPONSORED

Recent advances in the use of CAR T-cell therapies in relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma

In this webinar, Professor Martin Dreyling and an esteemed international panel of CAR T-cell therapy experts discuss the latest data on the safety, efficacy, and clinical impact of CAR T-cell therapies in the treatment of r/r DLBCL and r/r FL.

Please note, this webinar is not intended for healthcare professionals based in the US and UK.

Sponsored by:
  • Novartis Pharma AG
Chaired by: Prof. Martin Dreyling
Developed by: Springer Healthcare
Watch now